CA1042428A - Amide derivatives of vlb and leurocristine - Google Patents

Amide derivatives of vlb and leurocristine

Info

Publication number
CA1042428A
CA1042428A CA195,760A CA195760A CA1042428A CA 1042428 A CA1042428 A CA 1042428A CA 195760 A CA195760 A CA 195760A CA 1042428 A CA1042428 A CA 1042428A
Authority
CA
Canada
Prior art keywords
desacetyl
alk
formula
compound
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA195,760A
Other languages
English (en)
French (fr)
Other versions
CA195760S (en
Inventor
George J. Cullinan
Koert Gerzon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1042428A publication Critical patent/CA1042428A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Fodder In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CA195,760A 1973-04-02 1974-03-22 Amide derivatives of vlb and leurocristine Expired CA1042428A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34727573A 1973-04-02 1973-04-02

Publications (1)

Publication Number Publication Date
CA1042428A true CA1042428A (en) 1978-11-14

Family

ID=23363051

Family Applications (1)

Application Number Title Priority Date Filing Date
CA195,760A Expired CA1042428A (en) 1973-04-02 1974-03-22 Amide derivatives of vlb and leurocristine

Country Status (28)

Country Link
JP (2) JPS5919117B2 (nl)
AR (2) AR204004A1 (nl)
AT (1) AT340605B (nl)
BE (1) BE813168A (nl)
BG (3) BG21612A3 (nl)
CA (1) CA1042428A (nl)
CH (1) CH603669A5 (nl)
CS (1) CS185223B2 (nl)
CY (1) CY1044A (nl)
DD (1) DD113538A5 (nl)
DE (1) DE2415980A1 (nl)
DK (1) DK141511B (nl)
ES (2) ES424882A1 (nl)
FR (1) FR2223044B1 (nl)
GB (1) GB1463575A (nl)
HK (1) HK20180A (nl)
HU (1) HU171572B (nl)
IE (1) IE39071B1 (nl)
IL (1) IL44415A (nl)
KE (1) KE3028A (nl)
MY (1) MY8100025A (nl)
NL (1) NL181079C (nl)
PH (1) PH13623A (nl)
RO (2) RO73524B (nl)
SE (1) SE416206B (nl)
SU (4) SU731900A3 (nl)
YU (3) YU39719B (nl)
ZA (1) ZA741674B (nl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL48685A (en) * 1975-01-09 1980-03-31 Lilly Co Eli Amides of vincadioline and vinblastine
GR69783B (nl) * 1976-09-08 1982-07-07 Lilly Co Eli
US4096148A (en) * 1976-12-06 1978-06-20 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
USRE30560E (en) * 1976-12-06 1981-03-31 Eli Lilly And Company Oxazolidinedione derivatives of Vinca alkaloids
US4203898A (en) 1977-08-29 1980-05-20 Eli Lilly And Company Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4199504A (en) * 1978-05-15 1980-04-22 Eli Lilly And Company Bridged cathranthus alkaloid dimers
US4357334A (en) 1980-03-20 1982-11-02 Eli Lilly And Company Use of VLB 3-(2-chloroethyl) carboxamide in treating neoplasms
OA06421A (fr) * 1980-06-10 1981-09-30 Omnium Chimique Sa Procédé de préparation de dérivés N-(vinblastinoyl-23) d'acides aminés et de peptides.
LU83822A1 (fr) * 1981-12-08 1983-09-01 Omnichem Sa Derives n-(vinblastinoyl-23)d'acides amines,leur preparation et leur application therapeutique
FR2623504B1 (fr) * 1987-11-25 1990-03-09 Adir Nouveaux derives n-(vinblastinoyl-23) d'acide amino-1 methylphosphonique, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények
US5948750A (en) * 1996-10-30 1999-09-07 Merck & Co., Inc. Conjugates useful in the treatment of prostate cancer
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
AU2006207321B2 (en) 2005-01-21 2012-09-06 Astex Therapeutics Limited Pharmaceutical compounds
KR20080035630A (ko) 2005-07-18 2008-04-23 바이파 사이언스 인코포레이티드 암의 치료
US8143447B2 (en) 2006-09-05 2012-03-27 Bipar Sciences, Inc. Treatment of cancer
EP2061479A4 (en) 2006-09-05 2010-08-04 Bipar Sciences Inc FETTIC ACID SYNTHESIS INHIBITED BY PARP HEMMER AND TREATMENT PROCEDURES THEREWITH
JP5528807B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
JP5528806B2 (ja) 2006-10-12 2014-06-25 アステックス、セラピューティックス、リミテッド 複合薬剤
KR20100102609A (ko) 2007-11-12 2010-09-24 바이파 사이언스 인코포레이티드 Ｐａｒｐ 억제제를 단독으로 사용하거나 항종양제와 병용하여 유방암을 치료하는 방법
JP6250710B2 (ja) * 2013-04-19 2017-12-20 曁南大学 ビンブラスチン誘導体の調製方法
CN113456797B (zh) * 2021-06-18 2024-03-08 暨南大学 长春碱类衍生物在制备治疗骨肉瘤和/或软组织肉瘤药物中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE30561E (en) 1976-12-06 1981-03-31 Eli Lilly And Company Vinca alkaloid intermediates

Also Published As

Publication number Publication date
BG21235A3 (nl) 1976-03-20
IE39071B1 (en) 1978-08-02
BE813168A (fr) 1974-10-02
KE3028A (en) 1980-03-28
RO77533A (ro) 1982-02-01
GB1463575A (en) 1977-02-02
SU731900A3 (ru) 1980-04-30
RO73524B (ro) 1984-11-30
BG22831A3 (nl) 1977-04-20
JPS49128000A (nl) 1974-12-07
CS185223B2 (en) 1978-09-15
DK141511C (nl) 1980-09-29
DK141511B (da) 1980-04-08
DE2415980C2 (nl) 1989-11-09
DE2415980A1 (de) 1974-10-10
JPS59193895A (ja) 1984-11-02
CY1044A (en) 1980-08-01
YU113880A (en) 1982-05-31
ES446571A1 (es) 1977-06-16
MY8100025A (en) 1981-12-31
SE416206B (sv) 1980-12-08
ZA741674B (en) 1975-10-29
SU784783A3 (ru) 1980-11-30
ATA267974A (de) 1977-04-15
DD113538A5 (nl) 1975-06-12
YU81774A (en) 1982-05-31
HK20180A (en) 1980-04-25
AU6671974A (en) 1975-09-18
YU39719B (en) 1985-04-30
SU623522A3 (ru) 1978-09-05
NL181079C (nl) 1987-06-16
NL7404423A (nl) 1974-10-04
NL181079B (nl) 1987-01-16
CH603669A5 (nl) 1978-08-31
YU39876B (en) 1985-04-30
JPS6033837B2 (ja) 1985-08-05
IL44415A0 (en) 1974-06-30
JPS5919117B2 (ja) 1984-05-02
AR203882A1 (es) 1975-10-31
RO73524A (ro) 1984-10-31
AR204004A1 (es) 1975-11-12
HU171572B (hu) 1978-02-28
ES424882A1 (es) 1976-12-16
PH13623A (en) 1980-08-07
FR2223044B1 (nl) 1978-06-30
SU652896A3 (ru) 1979-03-15
BG21612A3 (nl) 1976-07-20
AT340605B (de) 1977-12-27
FR2223044A1 (nl) 1974-10-25
IL44415A (en) 1978-08-31
YU113980A (en) 1982-05-31
YU39875B (en) 1985-04-30
IE39071L (en) 1974-10-02

Similar Documents

Publication Publication Date Title
CA1042428A (en) Amide derivatives of vlb and leurocristine
US4203898A (en) Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
CA1196326A (en) Vinblastin-23-oyl amino acid derivatives
US4110339A (en) 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
CA1067073A (en) Amide derivatives of vlb, leurosidine, leurocristine and related dimeric alkaloid
US3752823A (en) N alkyl tetrahydrocarbazoles
CA1064918A (en) 8,8-disubstituted-6-methylergolines and related compounds
Gerecke et al. Selective Ether Cleavage in the Aporphine Series. Conversion of (S)‐Bulbocapnine into (S)‐Corytuberine and (S)‐Corydine Methyl Ether
CA1082179A (en) Amide derivatives of vlb, leurosidine, leurocristine and related dimeric alkaloids
US4108855A (en) Compounds of ergolene and ergoline structure and method for the preparation thereof
US4191688A (en) Amides of leurosine, leuroformine, desacetylleurosine and desacetylleuroformine
US4096148A (en) Oxazolidinedione derivatives of Vinca alkaloids
US4180581A (en) N-9,10-dihydrolysergyl-m-aminobenzoic acid amide derivative
US4115388A (en) 3'-Oxygenated derivatives of 4'-deoxy VLB "A" and "B" and related 1-formyl compounds
CA1142176B (en) 2-azaergolines and 2-aza-8 (or 9)-ergolenes
KR790000810B1 (ko) 빈브라스틴 유도체의 제조방법
USRE30561E (en) Vinca alkaloid intermediates
US4160767A (en) Vinca alkaloid intermediates
US4563464A (en) 2-Azabicyclo(2.2.2)octane derivatives and their use as immunosuppressive agents
Wasserman et al. The chemistry of vicinal tricarbonyls. Formation of carbazole derivatives.
US4199504A (en) Bridged cathranthus alkaloid dimers
USRE30560E (en) Oxazolidinedione derivatives of Vinca alkaloids
JPS60204762A (ja) 製薬学的に活性なピペリジン誘導体及びその使用
KR810001453B1 (ko) 인돌-디하이드로인돌 카복스 아마이드 이량체의 제조방법
AT345996B (de) Verfahren zur herstellung neuer amidderivate von vinblastin, leurosidin und leurocristin und ihrer saeureadditionssalze